Save your place

Sign in to WhoBought

Please try again later.

Avadel Pharmaceuticals plc (AVDL) institutional ownership

Market cap$1.1B SectorHealthcare
Funds holding · Q1 2026
199
reported AVDL position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
0 buyers · 199 sellers

Avadel Pharmaceuticals plc (AVDL) price and institutional activity

Dates

Q1 2026

$0 bought by 0 investors
$0 sold by 199 investors
BlackRockGendell Jeffrey L +197 more
Bought Sold Totals per quarter; hover a bar for the names.

Avadel Pharmaceuticals plc (AVDL) institutional activity · 199

Investor Type Est. change Change Δ Own Date
BlackRock · Exited
Change −7.0M Δ Own −100.0% Date Q1 2026
BlackRock Exited· Q1 2026 −7.0M −100.0% Q1 2026
Gendell Jeffrey L · Exited
Change −4.8M Δ Own −100.0% Date Q1 2026
Gendell Jeffrey L Exited· Q1 2026 −4.8M −100.0% Q1 2026
Weiss Asset Management LP · Exited
Change −4.5M Δ Own −100.0% Date Q1 2026
Weiss Asset Management LP Exited· Q1 2026 −4.5M −100.0% Q1 2026
Tig Advisors, LLC · Exited
Change −3.9M Δ Own −100.0% Date Q1 2026
Tig Advisors, LLC Exited· Q1 2026 −3.9M −100.0% Q1 2026
Tudor Investment Corp Et Al · Exited
Change −3.0M Δ Own −100.0% Date Q1 2026
Tudor Investment Corp Et Al Exited· Q1 2026 −3.0M −100.0% Q1 2026
Fil Ltd · Exited
Change −2.8M Δ Own −100.0% Date Q1 2026
Fil Ltd Exited· Q1 2026 −2.8M −100.0% Q1 2026
Vivo Capital, LLC · Exited
Change −2.7M Δ Own −100.0% Date Q1 2026
Vivo Capital, LLC Exited· Q1 2026 −2.7M −100.0% Q1 2026
State Street · Exited
Change −2.3M Δ Own −100.0% Date Q1 2026
State Street Exited· Q1 2026 −2.3M −100.0% Q1 2026
Geode · Exited
Change −2.2M Δ Own −100.0% Date Q1 2026
Geode Exited· Q1 2026 −2.2M −100.0% Q1 2026
Highbridge Capital Management LLC · Exited
Change −2.0M Δ Own −100.0% Date Q1 2026
Highbridge Capital Management LLC Exited· Q1 2026 −2.0M −100.0% Q1 2026
Wealth Effects LLC · Exited
Change −1.9M Δ Own −100.0% Date Q1 2026
Wealth Effects LLC Exited· Q1 2026 −1.9M −100.0% Q1 2026
Janus Henderson Group PLC · Exited
Change −1.8M Δ Own −100.0% Date Q1 2026
Janus Henderson Group PLC Exited· Q1 2026 −1.8M −100.0% Q1 2026
Pentwater Capital Management LP · Exited
Change −1.7M Δ Own −100.0% Date Q1 2026
Pentwater Capital Management LP Exited· Q1 2026 −1.7M −100.0% Q1 2026
Kennedy Capital Management LLC · Exited
Change −1.2M Δ Own −100.0% Date Q1 2026
Kennedy Capital Management LLC Exited· Q1 2026 −1.2M −100.0% Q1 2026
Water Island Capital LLC · Exited
Change −1.1M Δ Own −100.0% Date Q1 2026
Water Island Capital LLC Exited· Q1 2026 −1.1M −100.0% Q1 2026
Data through Q1 2026 · filed May 27, 2026
15 of 199

Famous investor activity in Avadel Pharmaceuticals plc (AVDL)

Avadel Pharmaceuticals plc (AVDL) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Weiss Andrew M. · Other Sell −$233M
Price $21.00 Qty −11.1M Owned 0 Trade date Feb 13, 2026 Filed date Feb 18, 2026
Weiss Andrew M. Other Sell $21.00 −11.1M −$233M 0 Feb 13, 2026 Feb 18, 2026
Rodriguez Susan · Officer Shares transferred outside the market (D), often for tax or as a gift, not a market sale -300K
Owned 0 Trade date Feb 12, 2026 Filed date Feb 12, 2026
Rodriguez Susan Officer Shares transferred outside the market (D), often for tax or as a gift, not a market sale -300K 0 Feb 12, 2026 Feb 12, 2026
Thornton Peter J. · Director 8 operations -356K
Price $21.00 Owned 0 Trade date Feb 12, 2026 Filed date Feb 12, 2026
Thornton Peter J. Director 8 operations $21.00 -356K 0 Feb 12, 2026 Feb 12, 2026
Seurer Jerad G. · Officer 8 operations -515K
Price $21.00 Owned 0 Trade date Feb 12, 2026 Filed date Feb 12, 2026
Seurer Jerad G. Officer 8 operations $21.00 -515K 0 Feb 12, 2026 Feb 12, 2026
Palczuk Linda · Director 9 operations -345K
Price $21.00 Owned 0 Trade date Feb 12, 2026 Filed date Feb 12, 2026
Palczuk Linda Director 9 operations $21.00 -345K 0 Feb 12, 2026 Feb 12, 2026
McHugh Thomas S. · Officer 7 operations -1.1M
Price $21.00 Owned 0 Trade date Feb 12, 2026 Filed date Feb 12, 2026
McHugh Thomas S. Officer 7 operations $21.00 -1.1M 0 Feb 12, 2026 Feb 12, 2026
McCamish Mark Anthony · Director 10 operations -380K
Price $21.00 Owned 0 Trade date Feb 12, 2026 Filed date Feb 12, 2026
McCamish Mark Anthony Director 10 operations $21.00 -380K 0 Feb 12, 2026 Feb 12, 2026
Glass Geoffrey Michael · Director 10 operations -408K
Price $21.00 Owned 0 Trade date Feb 12, 2026 Filed date Feb 12, 2026
Glass Geoffrey Michael Director 10 operations $21.00 -408K 0 Feb 12, 2026 Feb 12, 2026
Ende Eric J. · Director 9 operations -469K
Price $21.00 Owned 0 Trade date Feb 12, 2026 Filed date Feb 12, 2026
Ende Eric J. Director 9 operations $21.00 -469K 0 Feb 12, 2026 Feb 12, 2026
Divis Gregory J. · Director, Officer 12 operations -3.1M
Price $21.00 Owned 0 Trade date Feb 12, 2026 Filed date Feb 12, 2026
Divis Gregory J. Director, Officer 12 operations $21.00 -3.1M 0 Feb 12, 2026 Feb 12, 2026
Amin Naseem · Director 4 operations -94K
Price $21.00 Owned 0 Trade date Feb 12, 2026 Filed date Feb 12, 2026
Amin Naseem Director 4 operations $21.00 -94K 0 Feb 12, 2026 Feb 12, 2026
McCamish Mark Anthony · Director 2 operations 0
Owned 0 Trade date Feb 4, 2026 Filed date Feb 6, 2026
McCamish Mark Anthony Director 2 operations 0 0 Feb 4, 2026 Feb 6, 2026
Palczuk Linda · Director Gift (G) -11K
Owned 0 Trade date Sep 15, 2025 Filed date Sep 15, 2025
Palczuk Linda Director Gift (G) -11K 0 Sep 15, 2025 Sep 15, 2025
Glass Geoffrey Michael · Director Gift (G) -11K
Owned 0 Trade date Sep 15, 2025 Filed date Sep 15, 2025
Glass Geoffrey Michael Director Gift (G) -11K 0 Sep 15, 2025 Sep 15, 2025
Thornton Peter J. · Director 2 operations 22K
Owned 11K Trade date Jul 29, 2025 Filed date Jul 31, 2025
Thornton Peter J. Director 2 operations 22K 11K Jul 29, 2025 Jul 31, 2025
15 of 20
15 of 20 Sign in to continue to older insider transactions.

Avadel Pharmaceuticals plc (AVDL) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Janus Henderson Group PLC 13.3M
% of shares outstanding 13.8% Filing date Nov 14, 2024
Janus Henderson Group PLC 13.3M 13.8% Nov 14, 2024
Gendell Jeffrey L 2.9M
% of shares outstanding 7.1% Filing date Jun 3, 2022
Gendell Jeffrey L 2.9M 7.1% Jun 3, 2022
Kotler Kevin 3.4M
% of shares outstanding 5.8% Filing date Jun 6, 2022
Kotler Kevin 3.4M 5.8% Jun 6, 2022
Blackrock, Inc. 5.3M
% of shares outstanding 5.5% Filing date Nov 8, 2024
Blackrock, Inc. 5.3M 5.5% Nov 8, 2024
Polar Capital Holdings PLC 4.8M
% of shares outstanding 5.0% Filing date Nov 13, 2024
Polar Capital Holdings PLC 4.8M 5.0% Nov 13, 2024
Brandes Investment Partners, LP 2.6M
% of shares outstanding 4.4% Filing date Feb 8, 2022
Brandes Investment Partners, LP 2.6M 4.4% Feb 8, 2022
Kotler Kevin 3.7M
% of shares outstanding 4.1% Filing date Feb 12, 2024
Kotler Kevin 3.7M 4.1% Feb 12, 2024
Gendell Jeffrey L 3.5M
% of shares outstanding 3.9% Filing date Feb 13, 2024
Gendell Jeffrey L 3.5M 3.9% Feb 13, 2024
8 of 14

Avadel Pharmaceuticals plc (AVDL) ownership FAQ

Who owns AVDL?

199 reporting institutions disclosed AVDL position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.